Director

Stephanie Lovell

Director·TransMedics Group, Inc.

About

Stephanie Lovell has served on the TransMedics Board since March 2021.

She served as Executive Vice President, Medicare and Chief Legal Officer for Blue Cross Blue Shield of Massachusetts (BCBSMA) from July 2015 to December 2021, and previously as its Senior Vice President and General Counsel from December 2011 to July 2015; before BCBSMA she was Senior Vice President of Administration and General Counsel for Boston Medical Center from March 2007 to December 2011.

She also previously served as First Assistant Attorney General in the Massachusetts Office of the Attorney General and as Executive Director for the Massachusetts State Ethics Commission, and holds a philosophy degree from Hamilton College and a J.D. from Boston University School of Law.

Since March 2021
Age 66
Tenure 5 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director MR Merilee Raines Director; Chairperson of the Audit Committee

Roles

Organization Role Dates Details
TransMedics Group, Inc. Director March 2021–present Current role
Blue Cross Blue Shield of Massachusetts, Inc. Executive Vice President, Medicare and Chief Legal Officer July 2015-December 2021
Blue Cross Blue Shield of Massachusetts, Inc. Senior Vice President and General Counsel December 2011-July 2015
Boston Medical Center Senior Vice President of Administration and General Counsel March 2007-December 2011
Massachusetts Office of the Attorney General First Assistant Attorney General
Massachusetts State Ethics Commission Executive Director

External roles

Organization Role Dates
Accompany Health Director (private company)
Devoted Health Group, Inc. Director (private company)
Cyclerion Therapeutics, Inc. Director
The Partnership Inc. Director

Related

Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo